Although iron deficiency anemia is the most prevalent form of anemia globally, it may be underdiagnosed due to lack of awareness or methodical screening.
Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan
Plus, news about Xencor, Otsuka, Typewriter Therapeutics, Cassava Sciences, Enveric Biosciences, Viking Therapeutics and Janux Therapeutics: Next up in the PIPE bonanza: RNA company Avidity